Login / Signup

Cytokine Profiling in Different SARS-CoV-2 Genetic Variants.

Zoia R KorobovaNatalia A ArsentievaNatalia E LiubimovaOleg K BatsunovVladimir G DedkovAnna S GladkikhAlena A SharovaZhansaya AdishEkaterina I ChernykhVictor A KaschenkoVyacheslav A RatnikovVictor P GorelovOksana V StanevichAlexandr N KulikovDmitry E PevtsovAreg A Totolian
Published in: International journal of molecular sciences (2022)
This study is a successor of our previous work concerning changes in the chemokine profile in infection that are associated with different SARS-CoV-2 genetic variants. The goal of our study was to take into account both the virus and the host immune system by assessing concentrations of cytokines in patients infected with different SARS-CoV-2 variants (ancestral Wuhan strain, Alpha, Delta and Omicron). Our study was performed on 340 biological samples taken from COVID-19 patients and healthy donors in the timespan between May 2020 and April 2022. We performed genotyping of the virus in nasopharyngeal swabs, which was followed by assessment of cytokines' concentration in blood plasma. We noted that out of nearly 30 cytokines, only four showed stable elevation independently of the variant (IL-6, IL-10, IL-18 and IL-27), and we believe them to be 'constant' markers for COVID-19 infection. Cytokines that were studied as potential biomarkers lose their diagnostic value as the virus evolves, and the specter of potential targets for predictive models is narrowing. So far, only four cytokines (IL-6, IL-10, IL-18, and IL-27) showed a consistent rise in concentrations independently of the genetic variant of the virus. Although we believe our findings to be of scientific interest, we still consider them inconclusive; further investigation and comparison of immune responses to different variants of SARS-CoV-2 is required.
Keyphrases
  • sars cov
  • immune response
  • gene expression
  • genome wide
  • copy number
  • risk assessment
  • toll like receptor
  • clinical evaluation